论文部分内容阅读
作者对16例少精或无精患者以血管舒张素(Kallikrein)120ku/日并甲基维生素B_(12)治疗。治疗前患者精子计数平均值为32.5×10~6/ml(1×10~6/ml～100×10~6/ml),精于活动率平均值为35.8％(7.5～80％)。经用药1至10个月后,精于计数和活动率均显有意义的增加(前者P<0.05,后者P<0.01);其中精子计数的增加在用药2至4月后达最高值,5个月后又逐渐有下降的趋势。精子活动率在16例患者中有10例从治疗前的35.8±17.7％增加至64.6±26.6％。通过用药期间的观察,作者认为以血管舒张素
The author of 16 patients with oligozoospermia or azoospermia with Kallikrein 120ku / day and methyl vitamin B_ (12) treatment. The average sperm counts before treatment were 32.5 × 10 ~ 6 / ml (1 × 10 ~ 6 / ml ~ 100 × 10 ~ 6 / ml), and the average activity rate was 35.8% (7.5 ~ 80%). After treatment for 1 to 10 months, there was a significant increase (P <0.05 for the former and P <0.01 for the latter). The increase in sperm count reached the highest level after 2 to 4 months of treatment, After 5 months and gradually declining trend. Sperm motility increased from 35.8 ± 17.7% before treatment to 64.6 ± 26.6% in 10 of 16 patients. Through the observation of the medication, the author thinks that with angiotensin